This is a StreetInsider.com Premium Only Page

Geovax Labs Inc. (GOVX) –

Apr 15, 2024 04:05 PM Form DEF 14A GeoVax Labs, Inc. For: May 23

Apr 4, 2024 12:30 PM Geovax Labs (GOVX) Presents Data on GEO-CM04S1

Apr 4, 2024 12:30 PM GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Apr 3, 2024 04:03 PM Form PRE 14A GeoVax Labs, Inc. For: May 23

Mar 28, 2024 09:00 AM GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 14, 2024 06:05 AM Form EFFECT GeoVax Labs, Inc.

Mar 12, 2024 09:00 AM GeoVax to Present at the 36th Annual Roth Conference

Mar 11, 2024 04:13 PM Form 10-K/A GeoVax Labs, Inc. For: Dec 31

Mar 11, 2024 06:03 AM Form EFFECT GeoVax Labs, Inc.

Mar 11, 2024 06:03 AM Form EFFECT GeoVax Labs, Inc.

Mar 11, 2024 06:03 AM Form EFFECT GeoVax Labs, Inc.

Mar 11, 2024 06:03 AM Form EFFECT GeoVax Labs, Inc.

Mar 6, 2024 09:01 AM Geovax Labs (GOVX) Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 6, 2024 09:00 AM GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 1, 2024 04:11 PM Geovax Labs Inc. (GOVX) Files $100M Mixed Shelf

Mar 1, 2024 04:10 PM Form 8-K GeoVax Labs, Inc. For: Feb 29

Mar 1, 2024 04:09 PM Form S-3 GeoVax Labs, Inc.

Mar 1, 2024 04:05 PM Form POS AM GeoVax Labs, Inc.

Mar 1, 2024 04:05 PM Form POS AM GeoVax Labs, Inc.

Mar 1, 2024 04:05 PM Form POS AM GeoVax Labs, Inc.

Mar 1, 2024 04:04 PM Form POS AM GeoVax Labs, Inc.

Mar 1, 2024 06:48 AM GeoVax Labs, Inc. (GOVX) Reports FY Loss of $14.29

Feb 29, 2024 04:06 PM Form 10-K GeoVax Labs, Inc. For: Dec 31

Feb 29, 2024 04:00 PM GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 22, 2024 04:42 PM Form 4 GeoVax Labs, Inc. For: Feb 21 Filed by: DODD DAVID A

Feb 22, 2024 09:00 AM GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 19, 2024 09:00 AM GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 19, 2024 09:00 AM GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 16, 2024 04:08 PM Geovax Labs Inc. (GOVX) Regains Nasdaq Compliance

Feb 16, 2024 04:02 PM Form 8-K GeoVax Labs, Inc. For: Feb 16

Feb 14, 2024 03:38 PM Form SC 13G GeoVax Labs, Inc. Filed by: ARMISTICE CAPITAL, LLC

Feb 13, 2024 09:00 AM Geovax Labs (GOVX) Announces New Patent Issuances and Allowances

Feb 13, 2024 09:00 AM GeoVax Announces Multiple Patent Issuances and Allowances

Feb 7, 2024 04:44 PM Form 4 GeoVax Labs, Inc. For: Feb 07 Filed by: Reynolds Mark

Feb 6, 2024 09:00 AM Geovax Labs (GOVX) Reports Positive Interim Data From Phase 2 Trial of GEO-CM04S1

Feb 6, 2024 09:00 AM GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Jan 31, 2024 01:14 PM Form 8-K GeoVax Labs, Inc. For: Jan 30

Jan 29, 2024 09:00 AM Geovax Labs Inc. (GOVX) Announces 1:15 Reverse Share Split

Jan 29, 2024 09:00 AM GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 16, 2024 04:04 PM Form 8-K GeoVax Labs, Inc. For: Jan 16

Jan 12, 2024 04:01 PM Form 424B3 GeoVax Labs, Inc.

Jan 12, 2024 06:02 AM Form EFFECT GeoVax Labs, Inc.

Jan 8, 2024 09:00 AM GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 4, 2024 09:00 AM GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 3, 2024 09:00 AM Geovax Labs (GOVX) Announces Issuance of Malaria Vaccine Patent

Jan 3, 2024 09:00 AM GeoVax Announces Issuance of Malaria Vaccine Patent

Jan 2, 2024 04:13 PM Geovax Labs Inc. (GOVX) Announces 21.13M Share Offering by Selling Stockholders

Jan 2, 2024 04:11 PM Form S-1 GeoVax Labs, Inc.

Dec 27, 2023 09:00 AM GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 26, 2023 03:52 PM Form 4 GeoVax Labs, Inc. For: Dec 22 Filed by: McKee Kelly T. Jr.